The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
Stocks rose on Friday, but notched weekly losses as investors worried the U.S.-China trade war is hurting economic growth.US Marketsread more
The combination of mounting recession fears, bets on a more cautious Fed and a regular uptick in market volatility could spell more losses.Marketsread more
The therapy, Zolgensma, is a one-time treatment for spinal muscular atrophy — a muscle-wasting disease and leading genetic cause of infant mortality, affecting 1 in every...Biotech and Pharmaceuticalsread more
SpaceX has raised just over $1 billion in financing since the beginning of the year.Investing in Spaceread more
An analyst for Ark Invest, which has a major investment in Tesla, says recent drastic price-target cuts by others on Wall Street are missing the big picture.Investingread more
A federal judge in California has blocked President Donald Trump from building sections of his long-sought border wall with money secured under his declaration of a national...Politicsread more
Former Foreign Minister Boris Johnson is seen as the bookmaker's favorite to succeed outgoing Prime Minister Theresa May.Europe Politicsread more
The race is underway to find a vaccine that can control African swine fever, a highly contagious and deadly viral infection ravaging China's hog population. There is currently...Agricultureread more
Apple bought Tueo Health, which was developing tech to help parents monitor asthma symptoms in children, using a mobile app and commercial breathing sensors.Technologyread more
Cigna and Express Scripts shareholders have approved their merger, rebuking activist investor Carl Icahn and continuing the rapid consolidation in the health-care industry, the companies announced Friday.
In combining Cigna, a health insurer, and Express Scripts, a pharmacy benefit manager, the firms say they can improve care for patients and lower health-care costs. Their rivals are growing and pursuing deals of their own as the industry faces increasing costs and growing political pressure and braces for Amazon's entry.
Icahn opposed the deal earlier this month, arguing that Cigna was overpaying for a company whose business faces possible existential crises from regulators and Amazon. Icahn dropped his fight after influential proxy advisory firms Glass Lewis and Institutional Shareholder Services and hedge fund Glenview Capital Management supported the deal.
Cigna said preliminary results show roughly 90 percent of the votes that were cast backed the deal, while Express Scripts said 99 percent of its shareholders who voted approved the mergers. The final results will be filed with the Securities and Exchange Commission.
After securing shareholders' blessing, Cigna and Express Scripts now need the Justice Department's approval. The agency is also reviewing CVS Health's acquisition of Aetna, a deal that would also combine a pharmacy benefit manager and a health insurer.
CVS executives sounded optimistic about regulatory progress earlier this month. They told Wall Street analysts on an earnings call they now expect the deal to close at the end of the third or beginning of the fourth quarter, a more refined expectation than the previously forecast second half of the year.
Experts have closely watched AT&T's bid for Time Warner for any indications on how the Justice Department may handle these health-care deals. Similar to Cigna-Express Scripts and CVS-Aetna, the deal is an example of vertical integration, where the firms' businesses are similar but do not directly overlap.